Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: Insights for driven maturation and hypertrophic growth

Stem Cells and Development

Volumn 22, Issue 19, 2013, Pages 2678-2690

  Chow, Maggie Zi Ying ^a   Geng, Lin ^a   Kong, Chi Wing ^a   Keung, Wendy ^a   Fung, Jacky Chun Kit ^a   Boheler, Kenneth R ^a,b   Li, Ronald A ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; HISTONE H3; LYSINE; PHLEOMYCIN;

ANF GENE; ARTICLE; CTNT GENE; EMBRYONIC STEM CELL; EPIGENETICS; GENE; GENETIC TRANSCRIPTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; HUMAN CELL; MYH6 GENE; MYH7 GENE; MYL2 GENE; PHENOTYPE; PRIORITY JOURNAL;

ATRIAL NATRIURETIC FACTOR; BLEOMYCIN; CARDIAC MYOSINS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHROMATIN; DNA METHYLATION; ELECTROPHYSIOLOGICAL PHENOMENA; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEART VENTRICLES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; ION CHANNELS; ION TRANSPORT; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; PATCH-CLAMP TECHNIQUES; PHENOTYPE; PROMOTER REGIONS, GENETIC; VALPROIC ACID;

EID: 84884577797     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0125     Document Type: Article

References (57)

1. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
2. Blin G, D Nury, S Stefanovic, T Neri, O Guillevic, et al. (2010). A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120:1125-1139.
3. Blin G, T Neri, S Stefanovic and M Puceat. (2010). Human embryonic and induced pluripotent stem cells in basic and clinical research in cardiology. Curr Stem Cell Res Ther 5:215-226.
4. Yi BA, O Wernet and KR Chien. (2010). Pregenerative medicine: Developmental paradigms in the biology of cardiovascular regeneration. J Clin Invest 120:20-28.
5. Laflamme MA, KY Chen, AV Naumova, V Muskheli, JA Fugate, et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-1024.
6. Irion S, MC Nostro, SJ Kattman and GM Keller. (2008). Directed differentiation of pluripotent stem cells: From developmental biology to therapeutic applications. Cold Spring Harb Symp Quant Biol 73:101-110.
7. He JQ, Y Ma, Y Lee, JA Thomson and TJ Kamp. (2003). Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ Res 93:32-39.
8. Moore JC, J Fu, YC Chan, D Lin, H Tran, et al. (2008). Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun 372:553-558.
9. Liu J, JD Fu, CW Siu and RA Li. (2007). Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: Insights for driven maturation. Stem Cells 25:3038-3044.
10. Lieu DK, J Liu, CW Siu, GP McNerney, HF Tse, et al. (2009). Absence of transverse tubules contributes to non-uniform Ca(2 +) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells Dev 18:1493-1500.
11. Poon E, CW Kong and RA Li. (2011). Human pluripotent stem cell-based approaches for myocardial repair: From the electrophysiological perspective. Mol Pharm 8:1495-1504.
12. Klose RJ and Y Zhang. (2007). Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 8:307-318.
13. Ruthenburg AJ, H Li, DJ Patel and CD Allis. (2007). Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8:983-994.
14. Bannister AJ and T Kouzarides. (2011). Regulation of chromatin by histone modifications. Cell Res 21:381-395.
15. Schneider R, AJ Bannister, FA Myers, AW Thorne, C Crane-Robinson, et al. (2004). Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6:73-77.
16. Goldberg AD, CD Allis and E Bernstein. (2007). Epigenetics: A landscape takes shape. Cell 128:635-638.
17. Jenuwein T and CD Allis. (2001). Translating the histone code. Science 293:1074-1080.
18. Rada-Iglesias A and J Wysocka. (2011). Epigenomics of human embryonic stem cells and induced pluripotent stem cells: Insights into pluripotency and implications for disease. Genome Med 3:36.
19. Couture JF and RC Trievel. (2006). Histone-modifying enzymes: Encrypting an enigmatic epigenetic code. Curr Opin Struct Biol 16:753-760.
20. Campos EI and D Reinberg. (2009). Histones: Annotating chromatin. Annu Rev Genet 43:559-599.
21. Schwartz YB and V Pirrotta. (2007). Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8:9-22.
22. Barski A, S Cuddapah, K Cui, TY Roh, DE Schones, et al. (2007). High-resolution profiling of histone methylations in the human genome. Cell 129:823-837.
23. Bernstein BE, TS Mikkelsen, X Xie, M Kamal, DJ Huebert, et al. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315-326.
24. Mikkelsen TS, M Ku, DB Jaffe, B Issac, E Lieberman, et al. (2007). Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448:553-560.
25. Guenther MG, SS Levine, LA Boyer, R Jaenisch and RA Young. (2007). A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130:77-88.
26. Yang L, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, et al. (2008). Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524-528.
27. Fu JD, P Jiang, S Rushing, J Liu, N Chiamvimonvat, et al. (2010). Na + /Ca2 + exchanger is a determinant of excitationcontraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev 19:773-782.
28. Fu JD, SN Rushing, DK Lieu, CW Chan, CW Kong, et al. (2011). Distinct roles of microRNA-1 and - 499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One 6:e27417.
29. Marks PA, VM Richon, WK Kelly, JH Chiao and T Miller. (2004). Histone deacetylase inhibitors: Development as cancer therapy. Novartis Found Symp 259:269-281; discussion 281-288.
30. Wolffe AP and MA Matzke. (1999). Epigenetics: Regulation through repression. Science 286:481-486.
31. Cameron EE, KE Bachman, S Myohanen, JG Herman and SB Baylin. (1999). Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21:103-107.
32. Stein AB, TA Jones, TJ Herron, SR Patel, SM Day, et al. (2011). Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 121:2641-2650.
33. Liu Z, T Li, Y Liu, Z Jia, Y Li, et al. (2009). WNT signaling promotes Nkx2.5 expression and early cardiomyogenesis via downregulation of Hdac1. Biochim Biophys Acta 1793:300-311.
34. Zhang CL, TA McKinsey, S Chang, CL Antos, JA Hill, et al. (2002). Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479-488.
35. Wamstad JA, JM Alexander, RM Truty, A Shrikumar, F Li, et al. (2012). Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 151:206-220.
36. Paige SL, S Thomas, CL Stoick-Cooper, H Wang, L Maves, et al. (2012). A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell 151:221-232.
37. Lieu DK, JD Fu, N Chiamvimonvat, KC Tung, GP McNerney, et al. (2013). Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol 6:191-201.
38. Kaichi S, K Hasegawa, T Takaya, N Yokoo, T Mima, et al. (2010). Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res 88:314-323.
39. Kawamura T, K Ono, T Morimoto, H Wada, M Hirai, et al. (2005). Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J Biol Chem 280:19682-19688.
40. Johannessen CU and SI Johannessen. (2003). Valproate: Past, present, and future. CNS Drug Rev 9:199-216.
41. Bradbury CA, FL Khanim, R Hayden, CM Bunce, DA White, et al. (2005). Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19:1751-1759.
42. Harikrishnan KN, TC Karagiannis, MZ Chow and A El-Osta. (2008). Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments. Cell Cycle 7:468-476.
43. Binah O, K Dolnikov, O Sadan, M Shilkrut, N Zeevi-Levin, et al. (2007). Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes. J Electrocardiol 40:S192-S196.
44. Liu J, DK Lieu, CW Siu, JD Fu, HF Tse, et al. (2009). Facilitated maturation of Ca2 + handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Am J Physiol Cell Physiol 297: C152-C159.
45. Lieu DK, YC Chan, CP Lau, HF Tse, CW Siu, et al. (2008). Overexpression of HCN-encoded pacemaker current silences bioartificial pacemakers. Heart Rhythm 5:1310-1317.
46. Chan YC, CW Siu, YM Lau, CP Lau, RA Li, et al. (2009). Synergistic effects of inward rectifier (I) and pacemaker (I) currents on the induction of bioengineered cardiac automaticity. J Cardiovasc Electrophysiol 20:1048-1054.
47. Backs J, K Song, S Bezprozvannaya, S Chang and EN Olson. (2006). CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116: 1853-1864.
48. Bush E, J Fielitz, L Melvin, M Martinez-Arnold, TA McKinsey, et al. (2004). A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci U S A 101:2870-2875.
49. Chang S, TA McKinsey, CL Zhang, JA Richardson, JA Hill, et al. (2004). Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24:8467-8476.
50. Bradner JE, N West, ML Grachan, EF Greenberg, SJ Haggarty, et al. (2010). Chemical phylogenetics of histone deacetylases. Nat Chem Biol 6:238-243.
51. Antos CL, TA McKinsey, M Dreitz, LM Hollingsworth, CL Zhang, et al. (2003). Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278:28930-28937.
52. Cardinale JP, S Sriramula, R Pariaut, A Guggilam, N Mariappan, et al. (2010). HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 56:437-444.
53. Cao DJ, ZV Wang, PK Battiprolu, N Jiang, CR Morales, et al. (2011). Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A 108:4123-4128.
54. Kong Y, P Tannous, G Lu, K Berenji, BA Rothermel, et al. (2006). Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113:2579-2588.
55. Ahmad F, JG Seidman and CE Seidman. (2005). The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 6:185-216.
56. Moorman AF and VM Christoffels. (2003). Cardiac chamber formation: Development, genes, and evolution. Physiol Rev 83:1223-1267.
57. Brasacchio D, J Okabe, C Tikellis, A Balcerczyk, P George, et al. (2009). Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58:1229-1236.